You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 6, June 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The Appropriateness of Curettage and Electrodesiccation for the Treatment of Basal Cell Carcinomas

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In the article by Thissen et al1 in the October issue of the Archives of Dermatology, published data from our institution were quoted. The article compared the recurrence rates of basal cell carcinomas (BCCs) following different treatment modalities, including Mohs micrographic surgery, surgical excision, and curettage and electrodesiccation (C&E). They presented subsets of the C&E data from a 1977 study by Kopf et al2 from our institution as 3 separate studies. The highest rate of 18.8% cumulative recurrence at 5 years corresponded to C&E performed by resident physicians-in-training at the Skin and Cancer Unit of New York University Medical Center, New York. NY, from 1958 to 1962. Because of this finding, a greater effort was made to teach and supervise residents in this operative procedure. As a result, the cumulative recurrence rate of BCC at 5 years following C&E by resident physicians dropped to 9.6% as measured in 1970. . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.